Hopefully the market likes this update yet the reality is the FY24 EBIT result is a 60% decline. Think it will take more than a couple of weeks of positive sales growth on the back of a collaboration to convince me this has truly started a turn around. Even with sales improving and margin holding ground the 2H EBIT loss is more than double that of the 2H in FY23.
Cash and inventory well managed as has always been the case. Surely the Board's rhetoric of having to borrow money for a buyback is losing some credibility now.
- Forums
- ASX - By Stock
- Ann: FY24 Trading Update
DSK
dusk group limited
Add to My Watchlist
1.74%
!
87.5¢

Hopefully the market likes this update yet the reality is the...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
87.5¢ |
Change
0.015(1.74%) |
Mkt cap ! $54.48M |
Open | High | Low | Value | Volume |
86.0¢ | 89.5¢ | 85.5¢ | $103.2K | 118.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 392 | 86.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
87.5¢ | 24999 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 392 | 0.860 |
3 | 123577 | 0.850 |
4 | 140124 | 0.840 |
1 | 2600 | 0.830 |
1 | 582 | 0.820 |
Price($) | Vol. | No. |
---|---|---|
0.875 | 24999 | 1 |
0.900 | 17470 | 2 |
0.905 | 10999 | 1 |
0.920 | 23968 | 1 |
0.930 | 3000 | 1 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
DSK (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online